Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06251687 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis

StatusRecruiting
PhaseNot applicable
Started2024-02-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 10, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-02-07
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
2024-02-01
Original filing
The goal of this clinical study is to learn about the diagnostic effectiveness, safety, and influencing factors of transbronchial cryobiopsy（TBLC）in progressive pulmonary fibrosis. The main question it aims to answer are: • Determine the prognosis, health economics, and therapeutic strategy changes of patients with TBLC retrograde malleable pulmonary fibrosis. Participants will be randomly divided into two groups, and received TBLB or TBLC.
Trial Details
NCT Number NCT06251687
Lead Sponsor China-Japan Friendship Hospital
Conditions Pulmonary Fibrosis, Transbronchial Cryobiopsy
Enrollment 100 participants
Start Date 2024-02-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-10